Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial.

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Elisa Pose; Laura Napoleone; Ahmed Al Amin; Daniela Campion; Cesar Jimenez; Salvatore Piano; Olivier Roux; Frank Erhard Uschner; Frank Erhard Uschner; Koos de Wit; Giacomo Zaccherini; Carlo Alessandria; Paolo Angeli; Mauro Bernardi; Ulrich Beuers; Paolo Caraceni; François Durand; Rajeshwar P. Mookerjee; Jonel Trebicka; Victor Vargas; Raúl J. Andrade; Marta Carol; Judit Pich; Juan Ferrero; Gema D

Journal title: lancet. Gastroenterology & hepatology, 5(1), 31 - 41. Elsevier Limited

Journal number: 1

Journal publisher: -

Published year: 2020

Published pages: 31-41

DOI identifier: 10.1016/s2468-1253(19)30320-6